|
Depo-subq Provera 104Drug - Depo-subq Provera 104 The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; SUBCUTANEOUS
Active Ingredient(s) -
Medroxyprogesterone Acetate
Strength -
104MG/0.65ML
Applicant -
PFIZER
New Drug Application (NDA) Number -
021583
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Dec 17, 2004
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Pfizer Agricultural Div
Depo-subq Provera 104
Depo-provera 150mg/ml Injectable; Injection
Depo-provera 400mg/ml Injectable; Injection Medroxyprogesterone Acetate 150mg/ml Injectable; Injection Medroxyprogesterone Acetate 150mg/ml Injectable; Injection Depo-subq Provera 104 104mg/0.65ml Injectable; Subcutaneous Meclofenamate Sodium Eq 50mg Base Capsule; Oral Meclofenamate Sodium Eq 50mg Base Capsule; Oral Meclomen Eq 100mg Base Capsule; Oral Meclomen Eq 50mg Base Capsule; Oral Depo-provera 100mg/ml **federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons** Injectable; Injection NewDrugInformation |